Organon (FRA:7XP) Long-Term Debt : €8,009 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Long-Term Debt?

Organon's Long-Term Debt for the quarter that ended in Mar. 2024 was €8,009 Mil.

Organon's quarterly Long-Term Debt declined from Sep. 2023 (€8,101 Mil) to Dec. 2023 (€8,025 Mil) and declined from Dec. 2023 (€8,025 Mil) to Mar. 2024 (€8,009 Mil).

Organon's annual Long-Term Debt increased from Dec. 2021 (€8,076 Mil) to Dec. 2022 (€8,406 Mil) but then declined from Dec. 2022 (€8,406 Mil) to Dec. 2023 (€8,025 Mil).

Organon Long-Term Debt Historical Data

The historical data trend for Organon's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Long-Term Debt Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

63.00

8,075.63

8,406.32

8,024.67

Organon Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial														8,128.60	8,050.41	8,101.30	8,024.67	8,008.60

Organon (FRA:7XP) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Organon Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Organon's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon (FRA:7XP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (FRA:7XP) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

OGN:USA OGN:Mexico 1OGN:Italy 0A9W:UK 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.

Organon (FRA:7XP) Headlines

No Headlines